Findings indicate that excessive somatostatin inhibits glucagon secretion in type 1 diabetes, offering a novel target for hypoglycemia management strategies.
Why hypoglycemia-induced glucagon secretion becomes impaired in diabetes
- Post author:
- Post published:
- Post category:uncategorized